Winton Group LTD Esperion Therapeutics, Inc. Transaction History

Winton Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$19.4 - $28.71 $151,708 - $224,512	-7,820 Closed	0 $0
Q1 2021 Jul 21, 2021	BUY	$25.12 - $36.89 $196,438 - $288,479	7,820 New	7,820 $219,000
Q4 2018 Feb 05, 2019	SELL	$36.99 - $59.11 $190,424 - $304,298	-5,148 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$40.74 - $51.41 $108,572 - $137,007	-2,665 Reduced 34.11%	5,148 $0
Q2 2018 Aug 20, 2018	BUY	$36.2 - $76.4 $2,389 - $5,042	66 Added 0.85%	7,813 $0
Q1 2018 May 21, 2018	BUY	$65.94 - $80.76 $510,837 - $625,647	7,747 New	7,747 $0

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $155M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.